These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24721587)

  • 1. Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.
    He L; Wickremasingha P; Lee J; Tao B; Mendell-Harary J; Walker J; Wight D
    Diabetes Res Clin Pract; 2014 Jun; 104(3):401-9. PubMed ID: 24721587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil.
    He L; Wickremasingha P; Lee J; Tao B; Mendell-Harary J; Walker J; Wight D
    J Clin Pharmacol; 2014 Jan; 54(1):61-9. PubMed ID: 24019110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.
    Rigby SP; Handelsman Y; Lai YL; Abby SL; Tao B; Jones MR
    Endocr Pract; 2010; 16(1):53-63. PubMed ID: 19789153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics.
    Jones MR; Baker BA; Mathew P
    Clin Pharmacokinet; 2004; 43(13):943-50. PubMed ID: 15509187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No pharmacokinetic interaction between ipragliflozin and sitagliptin, pioglitazone, or glimepiride in healthy subjects.
    Smulders RA; Zhang W; Veltkamp SA; van Dijk J; Krauwinkel WJ; Keirns J; Kadokura T
    Diabetes Obes Metab; 2012 Oct; 14(10):937-43. PubMed ID: 22587345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide.
    Brown KS; Armstrong IC; Wang A; Walker JR; Noveck RJ; Swearingen D; Allison M; Kissling JC; Kisicki J; Salazar DE
    J Clin Pharmacol; 2010 May; 50(5):554-65. PubMed ID: 19789374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent.
    Donovan JM; Stypinski D; Stiles MR; Olson TA; Burke SK
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):681-90. PubMed ID: 11300370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.
    Kasichayanula S; Liu X; Shyu WC; Zhang W; Pfister M; Griffen SC; Li T; LaCreta FP; Boulton DW
    Diabetes Obes Metab; 2011 Jan; 13(1):47-54. PubMed ID: 21114603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-dose administration of sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not alter the single-dose pharmacokinetics of rosiglitazone in healthy subjects.
    Mistry GC; Bergman AJ; Luo WL; Cilissen C; Haazen W; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2007 Feb; 47(2):159-64. PubMed ID: 17244766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of colesevelam on lovastatin pharmacokinetics.
    Donovan JM; Kisicki JC; Stiles MR; Tracewell WG; Burke SK
    Ann Pharmacother; 2002 Mar; 36(3):392-7. PubMed ID: 11895049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Herman GA; Bergman A; Yi B; Kipnes M;
    Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men.
    Moon SJ; Yu KS; Kim MG
    Clin Ther; 2020 Jun; 42(6):1047-1057. PubMed ID: 32362346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.
    Patel A; Shah T; Shah G; Jha V; Ghosh C; Desai J; Khamar B; Chakraborty BS
    Am J Cardiovasc Drugs; 2010; 10(2):95-103. PubMed ID: 20334446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of phenytoin: unaltered by enalapril and amlodipine in rhesus monkeys.
    Badyal DK; Garg SK; Bhargava VK; Majumdar S
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):251-4. PubMed ID: 10365321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of simvastatin on the pharmacokinectics of sitagliptin.
    Cerra M; Luo WL; Li SX; Matthews C; O'Neill EA; Wagner JA; Stoch SA; Anderson MS
    J Popul Ther Clin Pharmacol; 2012; 19(3):e356-60. PubMed ID: 23077137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
    Marino MR; Langenbacher KM; Hammett JL; Nichola P; Uderman HD
    J Clin Psychopharmacol; 1997 Feb; 17(1):27-33. PubMed ID: 9004054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
    Shang Q; Liu MK; Saumoy M; Holst JJ; Salen G; Xu G
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G815-23. PubMed ID: 22281473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Epilepsy Res; 2014 Nov; 108(9):1519-32. PubMed ID: 25219351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colesevelam hydrochloride: a novel bile acid-binding resin.
    Aldridge MA; Ito MK
    Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a single cyclosporine dose on the single-dose pharmacokinetics of sitagliptin (MK-0431), a dipeptidyl peptidase-4 inhibitor, in healthy male subjects.
    Krishna R; Bergman A; Larson P; Cote J; Lasseter K; Dilzer S; Wang A; Zeng W; Chen L; Wagner J; Herman G
    J Clin Pharmacol; 2007 Feb; 47(2):165-74. PubMed ID: 17244767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.